Orlaith Brennan

Dr. Orlaith Brennan


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2005 in Current Osteoporosis Reports
Verified
Journal Article
Closed access
PDF file
Fergal O'BrienFergal O'Brien
Fergal O'Brien
OBOrlaith Brennan
Orlaith Brennan
OKOran D Kennedy
Oran D Kennedy
TLT. Clive Lee
T. Clive Lee

1 September 2016 in Chem
Verified
Journal Article
Closed access
ESEsther M. Surender
Esther M. Surender
SCSteve Comby
Steve Comby
BCBrenton Cavanagh
Brenton Cavanagh
OBOrlaith Brennan
Orlaith Brennan
TLT. Clive Lee
T. Clive Lee
TGThorfinnur Gunnlaugsson
Thorfinnur Gunnlaugsson

1 March 2009 in Journal of Biomechanics
Verified
Journal Article
Closed access
OBOrlaith Brennan
Orlaith Brennan
OKOran D Kennedy
Oran D Kennedy
TLT.C. Lee
T.C. Lee
SRS.M. Rackard
S.M. Rackard
Fergal O'BrienFergal O'Brien
Fergal O'Brien

9 February 2009 in Journal of Orthopaedic Research
Verified
Journal Article
Open access
PDF file
OKOran D Kennedy
Oran D Kennedy
OBOrlaith Brennan
Orlaith Brennan
SRSusan M. Rackard
Susan M. Rackard
ASAnthony Staines
Anthony Staines
Fergal O'BrienFergal O'Brien
Fergal O'Brien
TLT. Clive Lee
T. Clive Lee
Compact bone makes up approximately 80% of the human skeleton by mass; but there are little data available on the effects of increased bone turnover on compact bone mechanical and material properties. This study addresses this question by measuring intracortical remodeling, resorption cavity number, and porosity in an ovariectomized (OVX) sheep model, and measures changes in biomechanical properties. Thirty‐eight sheep were divided into two groups. Group 1 were controls (n = 19), and Group 2 were ovariectomized (OVX; n = 19). Fluorochrome dyes were administered intravenously to both groups at five time points over 12 months post‐OVX to label sites of bone turnover. At 12 months post‐OVX all animals were euthanized. Samples were harvested from the left metatarsal and were analyzed for intracortical bone turnover at five time points, the number of resorption cavities, and the level of intracortical porosity. The effects of these parameters on bone biomechanical properties were then measured. Bone turnover was increased in the OVX group at 6, 9, and 12 months (p < 0.05). Resorption was also higher in the OVX group at 12 months (p < 0.05). Furthermore, porosity was significantly increased in the OVX group at 12 months (p < 0.05). Stiffness and yield strength were reduced in the OVX group compared to controls (p = 0.05). Ultimate compressive strength and work to fracture did not differ between groups. These findings provide new insights into the mechanisms and effects of increased bone turnover on bone material and microstructural properties. © 2008 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 27:303–309, 2009

30 September 2010 in Journal of Orthopaedic Research
Verified
Journal Article
Open access
PDF file
OBOrlaith Brennan
Orlaith Brennan
OKOran D Kennedy
Oran D Kennedy
TLT. Clive Lee
T. Clive Lee
SRSusan M. Rackard
Susan M. Rackard
Fergal O'BrienFergal O'Brien
Fergal O'Brien
It has been proposed that osteocyte viability plays an important role in bone integrity, and that bone loss in osteoporosis may be partially due to osteocyte cell death following estrogen depletion. Osteoporosis treatments such as bisphosphonates can inhibit osteocyte apoptosis which in turn may also reduce remodeling. Consequently, microcracks in bone which are normally repaired by bone remodeling may accumulate. This study used an ovine model of osteoporosis to examine the effects of estrogen depletion and bisphosphonates on osteocyte apoptosis and microdamage accumulation. Skeletally mature ewes were randomly assigned into two equal groups; ovariectomy (OVX) and a non‐treatment group (control). Half of these animals were sacrificed 12 months post‐OVX. Twenty months post‐OVX, a number of OVX animals were randomly selected and each received a supra‐pharmacological dose of the bisphosphonate, zoledronic acid (Zol). This group and all the remaining animals were sacrificed 31 months post‐OVX. A compact bone specimen was removed from the left metacarpal of each animal; half was used for osteocyte apoptosis detection and the remainder for microdamage analysis. Estrogen deficiency resulted in significant increases in the levels of osteocyte apoptosis while zoledronic acid significantly reduced the level of apoptosis in osteocytes. Zoledronic acid treatment resulted in the formation of more microcracks. However, these cracks were shorter than in control or OVX groups which may provide one explanation as to why increased damage levels following bisphosphonate treatment have not lead to increased fractures. This study also provides additional evidence of the importance of estrogen in preserving the osteocyte network. © 2010 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 29:419–424, 2011

1 February 2018 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Closed access
MCM. Clare Caraher
M. Clare Caraher
ASAntonia Sophocleous
Antonia Sophocleous
JBJ. Renwick Beattie
J. Renwick Beattie
OOOlive O'DRiscoll
Olive O'DRiscoll
NCNiamh M. Cummins
Niamh M. Cummins
AIAymen I Idris
Aymen I Idris